Róbert Gábor Kiss
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management 10
-
- Antiplatelet Therapy and Cardiovascular Diseases 35
- Acute Myocardial Infarction Research 29
- Atrial Fibrillation Management and Outcomes 19
- Cardiovascular Function and Risk Factors 11
- Cardiac Arrhythmias and Treatments 11
- Surgery top 10%
- Coronary Interventions and Diagnostics 17
- Hematology top 10%
-
- Cardiac Imaging and Diagnostics 11
Róbert Gábor Kiss
88 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Internal Medicine 357
- Cardiology and Cardiovascular Medicine 1.2k
- Endocrinology, Diabetes and Metabolism 267
- Surgery 443
- Hematology 96
Countries citing papers authored by Róbert Gábor Kiss
This map shows the geographic impact of Róbert Gábor Kiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Róbert Gábor Kiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Róbert Gábor Kiss more than expected).
Fields of papers citing papers by Róbert Gábor Kiss
This network shows the impact of papers produced by Róbert Gábor Kiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Róbert Gábor Kiss. The network helps show where Róbert Gábor Kiss may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Róbert Gábor Kiss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillationbreakdown → | 2025 | 31 |
| 3 | 2024 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 2 | |
| 9 | 2021 | 10 | |
| 10 | 2021 | 42 | |
| 11 | Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitusbreakdown → | 2020 | 313 |
| 12 | 2020 | 7 | |
| 13 | 2019 | 12 | |
| 14 | 2019 | 5 | |
| 15 | 2018 | 6 | |
| 16 | 2014 | 2 | |
| 17 | 2013 | 15 | |
| 18 | 2013 | 8 | |
| 19 | 2012 | 10 | |
| 20 | 2007 | 11 |
About Róbert Gábor Kiss
Róbert Gábor Kiss is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery, having authored 93 papers that have together received 1.7k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (35 papers), Acute Myocardial Infarction Research (29 papers), Atrial Fibrillation Management and Outcomes (19 papers), Coronary Interventions and Diagnostics (17 papers), Cardiac Imaging and Diagnostics (11 papers), Cardiovascular Function and Risk Factors (11 papers), Cardiac Arrhythmias and Treatments (11 papers) and Venous Thromboembolism Diagnosis and Management (10 papers). The work is most often cited by research in Internal Medicine (357 citations), Cardiology and Cardiovascular Medicine (1.2k citations) and Endocrinology, Diabetes and Metabolism (267 citations). Róbert Gábor Kiss has collaborated with scholars based in Hungary, United States and Poland. Frequent co-authors include Sabina A. Murphy, Marc S. Sabatine, Marc P. Bonaca, Elliott M. Antman, Deepak L. Bhatt, Eugene Braunwald, Julia Kuder, Kurt Huber, Andrzej Budaj and Stephen D. Wiviott. Their work appears in journals such as New England Journal of Medicine, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.